Skip to main content
. 2021 Nov 24;102(11):001692. doi: 10.1099/jgv.0.001692

Fig. 5.

Fig. 5.

Nucleocapsid (n) and spike protein domain (s1)-specific IgG antibodies in SARS-CoV-2-infected patients in time. Serum samples were collected from SARS-CoV-2-infected patients available for multiple sampling and time points were fitted to patients’ availability. Sera were tested by ELISA on SARS-CoV-2 protein-covered plates, and normalized using reference serum (as described by Miura et al. [24, 25]). Individual values for each patient and time point are presented. Patients are identified by numbers in accordance with Table S1. Time points are presented as approximate weeks after infection. The shaded areas represent the 95 % confidence level interval for predictions from a linear model.